---
title: "热点基因集|ADP-Ribosylation相关基因-肝癌"
date: 2024-09-12T15:17:31Z
draft: ["false"]
tags: [
  "fetched",
  "学R时习之"
]
categories: ["Acdemic"]
---
热点基因集|ADP-Ribosylation相关基因-肝癌 by 学R时习之
------
<div><p><span>二磷酸腺苷核糖基化(ADP-ribosylation)属于蛋白质翻译后修饰(PTM)的一种，以NAD+作为供体，聚ADP核糖聚合酶(Poly ADP-ribose polymerases， PARPs)作为合成酶将ADP-ribose连接到目标蛋白上。PARylation(Poly-ADP-ribosylation, 聚二磷酸腺苷核糖基化)修饰广泛参与到转录调控、DNA损伤修复等过程。也就是咱们常说的PARP抑制剂的理论基础。</span><ne-clipboard source="https%3A%2F%2Fwww.yuque.com%2Fgaodashitou%2Fnyuczc%2Fvnf0p21tx30tu9z7"></ne-clipboard></p><p>下面学习下大神们是如何利用该热点进行分析发文的……</p><h1><span>Part1. 文章信息</span></h1><h1><span></span></h1><p>通过 ADP核糖基化相关基因分析破译肝细胞癌的免疫学和预后特征，并确定潜在的治疗靶点ARFIP2。</p><p><img data-imgfileid="100003805" data-ratio="0.5157407407407407" data-src="https://mmbiz.qpic.cn/sz_mmbiz_png/C0nicuvoMeDEibIAibFCGyvEyoeASlwIA9uf11pQYuWNVpiaaRafE2tnXPV9ch5FpZJ6MJicaxhXL80f2icibOa6R7Ulg/640?wx_fmt=png&amp;from=appmsg" data-type="png" data-w="1080" width="663" src="https://mmbiz.qpic.cn/sz_mmbiz_png/C0nicuvoMeDEibIAibFCGyvEyoeASlwIA9uf11pQYuWNVpiaaRafE2tnXPV9ch5FpZJ6MJicaxhXL80f2icibOa6R7Ulg/640?wx_fmt=png&amp;from=appmsg"></p><p>Deciphering the immunological and prognostic features of hepatocellular carcinoma through ADP-ribosylation–related genes analysis and identify potential therapeutic target ARFIP2.(PMID: 38302034)</p><p>Notes:</p><ul><li><p><code>ADPR</code>: ADP-ribosylation, 二磷酸腺苷核糖基化</p></li><li><p><code>ADPRI</code>: ADPR-related index, 二磷酸腺苷核糖基化相关指数</p></li><li><p><code>HCC</code>：Hepatocellular carcinoma，肝细胞癌</p></li><li><p>ADPR related genes, 作者从<code>GeneCards</code>和既往文献整理97个基因，在<code>Supplementary Table S1</code>。</p></li></ul><p><img data-imgfileid="100003804" data-ratio="0.6294536817102138" data-src="https://mmbiz.qpic.cn/sz_mmbiz_png/C0nicuvoMeDEibIAibFCGyvEyoeASlwIA9uGM1twvlrbZfYkP4liciaRjBA6l7oCvEK80X0F6p3NFqq1qcnYfvjZtQA/640?wx_fmt=png&amp;from=appmsg" data-type="png" data-w="842" width="632" src="https://mmbiz.qpic.cn/sz_mmbiz_png/C0nicuvoMeDEibIAibFCGyvEyoeASlwIA9uGM1twvlrbZfYkP4liciaRjBA6l7oCvEK80X0F6p3NFqq1qcnYfvjZtQA/640?wx_fmt=png&amp;from=appmsg"></p><p><img data-imgfileid="100003806" data-ratio="0.5111111111111111" data-src="https://mmbiz.qpic.cn/sz_mmbiz_png/C0nicuvoMeDEibIAibFCGyvEyoeASlwIA9uFbOAvflEbic2mnxvibh7u4wyYlRF5S3ibNdyWaRVUIb8VTjxFpQZJP54g/640?wx_fmt=png&amp;from=appmsg" data-type="png" data-w="1080" width="853" src="https://mmbiz.qpic.cn/sz_mmbiz_png/C0nicuvoMeDEibIAibFCGyvEyoeASlwIA9uFbOAvflEbic2mnxvibh7u4wyYlRF5S3ibNdyWaRVUIb8VTjxFpQZJP54g/640?wx_fmt=png&amp;from=appmsg"></p><hr><h1><span>Part2 结果解读</span></h1><p>作者针对收集到的97个基因进行差异分析，预后分析，构建预后模型，外部数据验证，最后锁定核心基因<code>ARFIP2</code>进行实验验证，还是比较经(tao)典(lu)的。</p><h2><strong><span>Part2.1 模型构建及验证</span></strong></h2><p>作者首先进行差异分析、预后分析，最终筛选得到4个基因构建预后模型，并在ICGC和LIRI-JP数据集中得到验证。</p><p><img data-imgfileid="100003808" data-ratio="1.0592592592592593" data-src="https://mmbiz.qpic.cn/sz_mmbiz_png/C0nicuvoMeDEibIAibFCGyvEyoeASlwIA9uiahzx4S0L9Iu6P8Kib4bwqiahNvLHpBn9nb98B6ckCVgCWtQt0MJ9LBFA/640?wx_fmt=png&amp;from=appmsg" data-type="png" data-w="1080" width="576" src="https://mmbiz.qpic.cn/sz_mmbiz_png/C0nicuvoMeDEibIAibFCGyvEyoeASlwIA9uiahzx4S0L9Iu6P8Kib4bwqiahNvLHpBn9nb98B6ckCVgCWtQt0MJ9LBFA/640?wx_fmt=png&amp;from=appmsg"><img data-imgfileid="100003807" data-ratio="1.2638888888888888" data-src="https://mmbiz.qpic.cn/sz_mmbiz_png/C0nicuvoMeDEibIAibFCGyvEyoeASlwIA9ubxrR61jGGtibqfBzhsOY6wuseHcfMicTtqqTXv9jzUYb0GZy5RTkE05g/640?wx_fmt=png&amp;from=appmsg" data-type="png" data-w="1080" width="561" src="https://mmbiz.qpic.cn/sz_mmbiz_png/C0nicuvoMeDEibIAibFCGyvEyoeASlwIA9ubxrR61jGGtibqfBzhsOY6wuseHcfMicTtqqTXv9jzUYb0GZy5RTkE05g/640?wx_fmt=png&amp;from=appmsg"></p><hr><h2><strong><span>Part2.2 riskScore周边</span></strong></h2><p>针对构建的模型进行基因突变、免疫相关分析、分子靶标预测、富集分析等。</p><h3><span>Part2.2.1 riskScore-基因突变</span></h3><p>根据riskScore的高低分为两组，展示高低表达组的突变情况，同时展示模型构建基因的染色体位置、CNV情况、TMB等。</p><p><img data-imgfileid="100003810" data-ratio="1.0425925925925925" data-src="https://mmbiz.qpic.cn/sz_mmbiz_png/C0nicuvoMeDEibIAibFCGyvEyoeASlwIA9uJtzMRianNFeTovAPy2qEibgw9NF0HWdxfZekHd2HPdkNRjicgbAR9z1vQ/640?wx_fmt=png&amp;from=appmsg" data-type="png" data-w="1080" width="585" src="https://mmbiz.qpic.cn/sz_mmbiz_png/C0nicuvoMeDEibIAibFCGyvEyoeASlwIA9uJtzMRianNFeTovAPy2qEibgw9NF0HWdxfZekHd2HPdkNRjicgbAR9z1vQ/640?wx_fmt=png&amp;from=appmsg"></p><hr><h3><span>Part2.2.2 riskScore-免疫分析</span></h3><p>针对riskScore进行高低分组，展示与多种方法计算的免疫细胞浸润情况、与免疫检查点、m6A调节因子及不同免疫评分的关系。</p><p><img data-imgfileid="100003812" data-ratio="0.5981481481481481" data-src="https://mmbiz.qpic.cn/sz_mmbiz_png/C0nicuvoMeDEibIAibFCGyvEyoeASlwIA9uJIw5nicOhN06m2RgicStJEYpdJa4Bacia52nrcxBLdtxIZ37vvldiawxlw/640?wx_fmt=png&amp;from=appmsg" data-type="png" data-w="1080" width="985" src="https://mmbiz.qpic.cn/sz_mmbiz_png/C0nicuvoMeDEibIAibFCGyvEyoeASlwIA9uJIw5nicOhN06m2RgicStJEYpdJa4Bacia52nrcxBLdtxIZ37vvldiawxlw/640?wx_fmt=png&amp;from=appmsg"><img data-imgfileid="100003809" data-ratio="0.8574074074074074" data-src="https://mmbiz.qpic.cn/sz_mmbiz_png/C0nicuvoMeDEibIAibFCGyvEyoeASlwIA9uW9xKLm2Kn9J6BqQGsAyeQnQibicQJ8GNBFbAwT0ibmQ7IJ8Cw41cICiaiaw/640?wx_fmt=png&amp;from=appmsg" data-type="png" data-w="1080" width="785" src="https://mmbiz.qpic.cn/sz_mmbiz_png/C0nicuvoMeDEibIAibFCGyvEyoeASlwIA9uW9xKLm2Kn9J6BqQGsAyeQnQibicQJ8GNBFbAwT0ibmQ7IJ8Cw41cICiaiaw/640?wx_fmt=png&amp;from=appmsg"></p><hr><h3><span>Part2.2.3 riskScore-药敏及分子预测</span></h3><p>既往上面的分析表明该预后模型比较厉害，那么具体有哪些应用？</p><p>当时是提供不同的作用靶点啦，随后作者利用<code>pRRophetic</code>计算药物的IC50, 并利用<code>Schrodinger</code>预测小分子药物。</p><p><img data-imgfileid="100003814" data-ratio="1.0962962962962963" data-src="https://mmbiz.qpic.cn/sz_mmbiz_png/C0nicuvoMeDEibIAibFCGyvEyoeASlwIA9uKgY6BxW3gEvtpibic9pKLUsaBfc5avibdEAKb5Q58AzEH7nRShwjicpUjg/640?wx_fmt=png&amp;from=appmsg" data-type="png" data-w="1080" width="610" src="https://mmbiz.qpic.cn/sz_mmbiz_png/C0nicuvoMeDEibIAibFCGyvEyoeASlwIA9uKgY6BxW3gEvtpibic9pKLUsaBfc5avibdEAKb5Q58AzEH7nRShwjicpUjg/640?wx_fmt=png&amp;from=appmsg"></p><hr><h3><span>Part2.2.4 riskScore-核心基因富集分析</span></h3><p>接下来针对ADPR related genes进行富集分析，同时收集临床样本证实模型构建基因的表达情况。</p><p><img data-imgfileid="100003811" data-ratio="0.85" data-src="https://mmbiz.qpic.cn/sz_mmbiz_png/C0nicuvoMeDEibIAibFCGyvEyoeASlwIA9unpH2zLvLTGX5sMK3erqYVUxYicyDmBsRqht1v8RQYiacoNKajITLPDiaQ/640?wx_fmt=png&amp;from=appmsg" data-type="png" data-w="1080" width="713" src="https://mmbiz.qpic.cn/sz_mmbiz_png/C0nicuvoMeDEibIAibFCGyvEyoeASlwIA9unpH2zLvLTGX5sMK3erqYVUxYicyDmBsRqht1v8RQYiacoNKajITLPDiaQ/640?wx_fmt=png&amp;from=appmsg"></p><hr><h2><strong><span>Part2.3 目标基因ARFIP2验证</span></strong></h2><p>最后作者选择<code>ARFIP2</code>基因敲低后进行验证，结果表明<code>ARFIP2</code>能通过调节细胞周期过程影响细胞增殖和迁移。</p><p><img data-imgfileid="100003815" data-ratio="1.0205338809034907" data-src="https://mmbiz.qpic.cn/sz_mmbiz_png/C0nicuvoMeDEibIAibFCGyvEyoeASlwIA9utPsOPp3pKW7zichRdibMToluBDQvpPoZOCIFrS0FL2nzYiadUP3p1k1cw/640?wx_fmt=png&amp;from=appmsg" data-type="png" data-w="974" width="487" src="https://mmbiz.qpic.cn/sz_mmbiz_png/C0nicuvoMeDEibIAibFCGyvEyoeASlwIA9utPsOPp3pKW7zichRdibMToluBDQvpPoZOCIFrS0FL2nzYiadUP3p1k1cw/640?wx_fmt=png&amp;from=appmsg"><img data-imgfileid="100003816" data-ratio="1.1166666666666667" data-src="https://mmbiz.qpic.cn/sz_mmbiz_png/C0nicuvoMeDEibIAibFCGyvEyoeASlwIA9uTJAjr46iauia5WiclkXnkUG94sCEvL85E9GIN7kDOXTXdxj0syDPt9EdQ/640?wx_fmt=png&amp;from=appmsg" data-type="png" data-w="1080" width="581" src="https://mmbiz.qpic.cn/sz_mmbiz_png/C0nicuvoMeDEibIAibFCGyvEyoeASlwIA9uTJAjr46iauia5WiclkXnkUG94sCEvL85E9GIN7kDOXTXdxj0syDPt9EdQ/640?wx_fmt=png&amp;from=appmsg"></p><hr><p>碎碎念：</p><ul><li><p><code>ADRP related genes</code>发文目前好像不多，可同期替换到其他癌种，结合单细胞、湿实验还是可以的。</p></li></ul><p>声明：本文仅供交流学习，禁止用于商业用途，如有侵权，请联系删除。️</p><p><mp-style-type data-value="3"></mp-style-type></p></div>  
<hr>
<a href="https://mp.weixin.qq.com/s/vDzphNDk-45sMXFBq0WzFw",target="_blank" rel="noopener noreferrer">原文链接</a>
